Sarcoidosis is a rare systemic disease that afflicts an estimated 200,000 people in the U.S., more often people who are Black and more women than men, particularly when it causes chronic skin disease.

Patients are currently being enrolled in the first clinical trial to investigate the efficacy of immunological therapy for chronic pulmonary sarcoidosis. The trial is being conducted by researchers at ...

Asymptomatic: hilar lymphadenopathy on routine chest x-ray in 30% to 60% of patients. Pulmonary: 20% to 30% of patients with symptoms; bronchial hyperreactivity in 20% of patients: Lymphatics: ...

A research project supported by the National Institutes of Health has developed a tool to rapidly and inexpensively diagnose sarcoidosis, a chronic inflammatory disease marked by the growth of tiny ...

Aspergillus is a fungus that may cause infections in humans, generally through the respiratory tract. While almost everyone has been exposed to Aspergillus at some point, actual infection does not ...

BASEL, Switzerland & LONDON & NEW YORK--(BUSINESS WIRE)--Roivant (Nasdaq: ROIV) and Kinevant Sciences, a clinical-stage biopharmaceutical company developing new medicines for rare inflammatory and ...

The cause of the inflammatory lung disease sarcoidosis is unknown. In a new study, researchers at Karolinska Institutet in Sweden have investigated whether a type of immune cell called a monocyte ...

Sarcoidosis is an inflammatory disease in which immune cells form tissue nodules in various organs, which can drastically impair organ function. Now a MedUni Vienna research team led by Thomas ...

Sarcoidosis is a rare systemic disease that afflicts an estimated 200,000 people in the US, more often people who are Black and more women than men, particularly when it causes chronic skin disease.

The last year has brought what seems like a lifetime of deprivation to many suffering through the pandemic. A year can feel like an eternity. But I’m living with a different sense of time. For me, a ...